Chi Advisors LLC Pliant Therapeutics, Inc. Call Options Transaction History

Chi Advisors LLC

  • $203 Million
  • Q3 2023

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$14.58 - $20.15 $104,976 - $145,080
7,200 Added 5.53%
137,500 $2.38 Million
Q2 2023

Aug 11, 2023
BUY
$18.12 - $30.56 $2.36 Million - $3.98 Million
130,300 New
130,300 $2.36 Million
Q4 2022

Feb 13, 2023
BUY
$17.0 - $25.43 $510,000 - $762,900
30,000 New
30,000 $579,000

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Chi Advisors LLC Portfolio

Follow Chi Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email